However, there was no correlation between AR expression and pCR rate in HR + /HER2-, HR + /HER2 + or HR-/HER2 + breast cancer (P = 0.651, P = 0.769 and P = 0.608, respectively) in this study. This evidence concerns the gene ERBB2 and breast cancer.